The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Open accessAbstract
Fanconi anemia (FA) is a human autosomal recessive cancer susceptibility disorder characterized by cellular sensitivity to mitomycin C and ionizing radiation. Although six FA genes (for subtypes A, C, D2, E, F, and G) have been cloned, their relationship to DNA repair remains unknown. In the current study, we show that a nuclear complex containing the FANCA, FANCC, FANCF, and FANCG proteins is required for the activation of the FANCD2 protein to a monoubiquitinated isoform. In normal (non-FA) cells, FANCD2 is monoubiquitinated in response to DNA damage and is targeted to nuclear foci (dots). Activated FANCD2 protein colocalizes with the breast cancer susceptibility protein, BRCA1, in ionizing radiation-induced foci and in synaptonemal complexes of meiotic chromosomes. The FANCD2 protein, therefore, provides the missing link between the FA protein complex and the cellular BRCA1 repair machinery. Disruption of this pathway results in the cellular and clinical phenotype common to all FA subtypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since BRCA1 interacts with FancD2 and mediates FancD2 foci formation after treatment with MMC (Bunting et al., 2012; Garcia-Higuera et al., 2001; Vandenberg et al., 2003)”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Garcia-Higuera et al., 2001
Experimental — accuracy not yet measuredIn the citing paper
“In addition, DNA damage induces the accumulation of BRCA-FA proteins in nuclear foci [33].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. J. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,804
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Joazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination
Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S., & Weissman, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11364 · Cited by 1,151
Cortez, D., Wang, Y., Qin, J., & Elledge, S. J. (1999) · Science · doi:10.1126/science.286.5442.1162 · Cited by 1,020
A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase.
Huibregtse, J. M., Scheffner, M., Beaudenon, S. L., & Howley, P. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2563 · Cited by 1,011
Ubiquitin-dependent c-Jun degradation in vivo is mediated by the δ domain
Treier, M., Staszewski, L. M., & Bohmann, D. (1994) · Cell · doi:10.1016/s0092-8674(94)90502-9 · Cited by 919
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Cited by
Sorted by citations
Items 901–1,000 of 1,000
FANCD2: A branch-point in DNA damage response?
Grompe, M. (2002) · Nature Medicine · doi:10.1038/nm0602-555 · Cited by 9
Self-citationYin, G. (2006) · Frontiers in bioscience · doi:10.2741/1899 · Cited by 9
The molecular biology of Fanconi anemia.
Tamary, H., Bar-Yam, R., Zemach, M., Dgany, O., Shalmon, L., & Yaniv, I. (2002) · PubMed · Cited by 9
Meyer, S., Barber, L. M., White, D. J., Will, A., Birch, J. M., Kohler, J., Ersfeld, K., Blom, E., Joenje, H., Eden, T. O. B., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.05985.x · Cited by 9
MEN1 and FANCD2 mediate distinct mechanisms of DNA crosslink repair
Marek, L. R., Kottemann, M. C., Glazer, P. M., & Bale, A. E. (2008) · DNA repair · doi:10.1016/j.dnarep.2007.12.009 · Cited by 9
Waisfisz, Q., Miyazato, A., de Winter, J. P., Liu, J. M., & Joenje, H. (2002) · BMC Hematology · doi:10.1186/1471-2326-2-5 · Cited by 9
TOPBP1 , CLSPN and PALB2 genes in familial breast cancer susceptibility
Erkko, H. (2008) · Cited by 9
Macaisne, N., Touzón, M. S., Rajkovic, A., & Yanowitz, J. L. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02494-0 · Cited by 8
Zhao, L., Li, Y., He, M., Song, Z. J., Lin, S., Yu, Z., Bai, X., WANG, N., & Wei, M. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2400 · Cited by 8
RetractedPanichnantakul, P., Patel, A., Tse, E. Y. W., & Wyatt, H. D. M. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103156 · Cited by 8
Expression of FANCD2 in sporadic breast cancer and clinicopathological analysis
Zhang, B., Chen, R., Lu, J., Shi, Q., Zhang, X., & Chen, J. (2010) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-010-0350-7 · Cited by 8
Regulation of Fanconi anemia protein FANCD2 monoubiquitination by miR-302
Suresh, B., Kumar, A. M., Jeong, H.-S., Cho, Y.-H., Ramakrishna, S., & Kim, K.-S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.127 · Cited by 8
Joaquin, A., & Fernández-Capetillo, Ó. (2012) · InTech eBooks · doi:10.5772/50863 · Cited by 14
Cell Cycle Control of Germ Cell Differentiation
Spiller, C. M., & Koopman, P. A. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-19065-0_13 · Cited by 8
BRCA1 and BRCA2 in Breast Cancer Predisposition and Recombination Control
Scully, R., & Xie, A. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048771.93906.3e · Cited by 8
Update on childhood neutropenia: molecular and clinical advances
Dror, Y., & Sung, L. (2004) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2004.06.013 · Cited by 8
Tsuchida, K., & Komatsu, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00915.x · Cited by 8
Investigation of FANCA gene in Fanconi anaemia patients in Iran
Mahjoubi, F., Moghadam, A. A. S., Reisi, N., & Parvaneh, V. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.180206 · Cited by 8
Functional Annotation of Deubiquitinating Enzymes Using RNA Interference
Dirac, A. M. G., Nijman, S. M. B., Brummelkamp, T. R., & Bernards, R. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)98045-2 · Cited by 8
De-ubiquitinating enzymes: intracellular signalling and disease
Johnston, J. A., & Burrows, J. F. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340764 · Cited by 8
Identification, developmental expression and regulation of the Xenopus ortholog of human FANCG/XRCC9
Stone, S., Sobeck, A., van Kogelenberg, M., de Graaf, B., Joenje, H., Christian, J. L., & Hoatlin, M. E. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01096.x · Cited by 8
Disruption of the fanconi anemia pathway in human cancer in the general population
Jacquemont, C. F., & Taniguchi, T. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3658 · Cited by 8
Self-citationCallén, E., Ramı́rez, M. J., Creus, A., Marcos, R., Frı́as, S., Molina, B., Badell, I., Olivé, T., Ortega, J., & Surrallés, J. (2002) · Carcinogenesis · doi:10.1093/carcin/23.8.1267 · Cited by 8
Vikhanskaya, F., & Broggini, M. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)19013-9 · Cited by 8
Fanconi Anemia: Challenges in Diagnosis and Management—A Case Series Report
Eghbali, A., Safdari, S. M., Roozbahani, M. Y., Tavajohi, K., & Hosseini, S. (2024) · Clinical Case Reports · doi:10.1002/ccr3.9583 · Cited by 7
Menin signaling and therapeutic targeting in breast cancer
Liu, P., Shi, C., Qiu, L., Shang, D., Tu, Z., Tu, Z., & Liu, H. (2024) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2024.101118 · Cited by 7
DNA Damage: Placing BRCA1 in the Proper Context
Aressy, B., & Greenberg, R. A. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.046 · Cited by 7
Grompe, M. (2003) · Nature Genetics · doi:10.1038/ng1003-113 · Cited by 7
Self-citationModulation of the Fanconi anemia pathway via chemically induced changes in chromatin structure
Vierra, D. A., Garzon, J. L., Rego, M. A., Adroved, M. M., Mauro, M., & Howlett, N. G. (2017) · Oncotarget · doi:10.18632/oncotarget.19470 · Cited by 7
Paquin, K. L., Mamrak, N. E., Garzon, J. L., Cantres-Velez, J. A., Azzinaro, P. A., Vuono, E. A., Lima, K. E., Camberg, J. L., & Howlett, N. G. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00194-19 · Cited by 7
Cyclin-Dependent Kinase-Mediated Phosphorylation of FANCD2 Promotes Mitotic Fidelity
Cantres-Velez, J. A., Blaize, J. L., Vierra, D. A., Boisvert, R. A., Garzon, J. L., Piraino, B., Tan, W., Deans, A. J., & Howlett, N. G. (2021) · Molecular and Cellular Biology · doi:10.1128/mcb.00234-21 · Cited by 8
Activation of the Fanconi anemia/BRCA pathway at low doses of ionization radiation
Bosch, P. C., Bogliolo, M., & Surrallés, J. (2015) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2015.06.010 · Cited by 7
Fanconi Anemia Founder Mutation in Macedonian Patients
Madjunkova, S., Kocheva, S. A., & Plaseska‐Karanfilska, D. (2013) · Acta Haematologica · doi:10.1159/000355191 · Cited by 7
The role of ubiquitin-binding domains in human pathophysiology
Sokratous, K., Hadjisavvas, A., Diamandis, E. P., & Kyriacou, K. C. (2014) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2014.915287 · Cited by 7
Fanconi anemia D2 protein is an apoptotic target mediated by caspases
Park, S.-J., Beck, B. D., Saadatzadeh, M. R., Haneline, L. S., Clapp, D. W., & Lee, S. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23161 · Cited by 7
Cross-links between Fanconi anaemia and BRCA2
West, S. C. (2003) · DNA repair · doi:10.1016/s1568-7864(02)00168-4 · Cited by 8
The Fanconi Anemia Pathway of DNA Repair and Human Cancer
Krishnan, V., Tay, L. S., & Ito, Y. (2015) · InTech eBooks · doi:10.5772/59995 · Cited by 7
Bick, G., Zhang, F., Meetei, A. R., & Andreassen, P. R. (2016) · Chromosoma · doi:10.1007/s00412-016-0602-9 · Cited by 8
Fanconi Anemia DNA Repair Pathway as a New Mechanism to Exploit Cancer Drug Resistance
Ghosal, K., Agatemor, C., Han, R. I., Ku, A. T., Thomas, S., & Mukherjee, S. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200103114556 · Cited by 8
Genetic instability in the RAD51 and BRCA1 regions in breast cancer
Nowacka‐Zawisza, M., Bryś, M., Romanowicz‐Makowska, H., Kulig, A., & Krajewska, W. M. (2006) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-006-0063-x · Cited by 7
Oncofertilité et cancer du sein
Sonigo, C., Grynberg, M., Bringer-Deutsch, S., & Sermondade, N. (2019) · Bulletin du Cancer · doi:10.1016/s0007-4551(20)30047-3 · Cited by 7
The fanconi anemia pathway promotes homologous recombination repair in DT40 cell line
Takata, M., Yamamoto, K., Matsushita, N., Kitao, H., Hirano, S., & Ishaiai, M. (2006) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-4896-8_17 · Cited by 7
Connecting Fanconi's anaemia to breast cancer predisposition
Venkitaraman, A. R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11414-0 · Cited by 7
Pipaón, C., Casado, J. A., Bueren, J. A., & Fernández-Luna, J. L. (2003) · Blood · doi:10.1182/blood-2003-06-2091 · Cited by 7
BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer
Sólyom, S. (2011) · Cited by 7
Hematopoietic Cell Transplantation for Fanconi Anemia
Wagner, J. E., MacMillan, M. L., & Auerbach, A. D. (2003) · Wiley eBooks · doi:10.1002/9780470987070.ch109 · Cited by 7
Haanpää, M. K. (2014) · Cited by 6
The emergence of Fanconi anaemia type S: a phenotypic spectrum of biallelic BRCA1 mutations
HUGHES, T. D., & Rose, A. M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1278004 · Cited by 7
Nakamura, J., Carro, S., Gold, A. R., & Zhang, Z. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.129149 · Cited by 6
Systemic Therapy for Hereditary Breast Cancers
Harvey-Jones, E. J., Lord, C. J., & Tutt, A. N. J. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.08.018 · Cited by 6
Defective FANCI Binding by a Fanconi Anemia-Related FANCD2 Mutant
Sato, K., Ishiai, M., Takata, M., & Kurumizaka, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114752 · Cited by 6
Stanley, E. C., Azzinaro, P. A., Vierra, D. A., Howlett, N. G., & Irvine, S. Q. (2016) · Evolutionary Bioinformatics · doi:10.4137/ebo.s37920 · Cited by 6
The role of ubiquitin signaling pathway on liver regeneration in rats
Yaylacı, A. Ö., & Canbek, M. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04482-5 · Cited by 6
Fanconi anemia pathway regulation by FANCI in prostate cancer
Kaljunen, H., Taavitsainen, S., Kaarijärvi, R., Takala, E., Paakinaho, V., Nykter, M., Bova, G. S., & Ketola, K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1260826 · Cited by 6
Andreev, V. I., Hristova, R. H., Asparuhova, M., Danovski, G., Stoynov, S., & Gospodinov, A. G. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.12.007 · Cited by 6
Understanding aplastic anaemia/bone-marrow failure syndromes
Ahmed, M., & Dokal, I. S. (2009) · Paediatrics and Child Health · doi:10.1016/j.paed.2009.04.004 · Cited by 6
Callén, E., Ramı́rez, M. J., Creus, A., Marcos, R., Ortega, J., Olivé, T., Badell, I., & Surrallés, J. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00081-7 · Cited by 6
Fanconi anemia: genetic analysis of a human disease using chicken system
Takata, M., Kitao, H., & Ishiai, M. (2007) · Cytogenetic and Genome Research · doi:10.1159/000103197 · Cited by 6
Transcription reprogramming and endogenous DNA damage
Li, L. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103754 · Cited by 5
Resistance to PARP Inhibitors Mediated by Secondary BRCA1/2 Mutations
Dhillon, K. K., & Taniguchi, T. (2015) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-14151-0_18 · Cited by 5
Self-citationOf Escherichia coli and Man: Understanding Glioma Resistance to Temozolomide Therapy
Chen, C. C., Kahle, K. T., Ng, K., Nitta, M., & D’Andrea, A. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_28 · Cited by 5
Self-citationProteolytic control of genome integrity at the replication fork
Rageul, J., Weinheimer, A. S., Park, J. J., & Kim, H. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102657 · Cited by 5
Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation
Dillon, B., Feben, C., Segal, D. G., du Plessis, J., Reynders, D. T., Wainwright, R., Poole, J., & Krause, A. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1351 · Cited by 5
DNA Damage Response Pathways and Cancer
Ford, J. M., & Kastan, M. B. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50013-0 · Cited by 5
Fanconi anemia and breast cancer: what's the connection?
Youssoufian, H. (2001) · Nature Genetics · doi:10.1038/86832 · Cited by 5
Ubiquitin and SUMO pathways in DNA replication and replication-coupled repair
Fiedorowicz, L., Baxley, R. M., Hendrickson, E. A., & Bielinsky, A. (2025) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2025.2574638 · Cited by 4
Huang, F., Zhong, Y., Sun, G., Xu, Q.-J., Xing, Z., Chen, K.-H., Liao, L.-S., & Dong, M. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08282-3 · Cited by 4
Role of various DNA repair pathways in chromosomal inversion formation in CHO mutants
Cartwright, I. M., & Kato, T. A. (2015) · International Journal of Radiation Biology · doi:10.3109/09553002.2015.1101499 · Cited by 4
Bogliolo, M., & Surrallés, J. (2013) · Cited by 4
Aurora A kinase is required for activation of the Fanconi anemia/ BRCA pathway upon DNA damage
Chun, M. J., Hwang, S. K., Kim, H. G., Goh, S., Kim, S., & Lee, C. H. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12087 · Cited by 4
Role of Protein Ubiquitination and its Functional Importance
Wang, X., Wei, X., & Zhang, H. (2015) · Scientia Sinica Vitae · doi:10.1360/n052015-00065 · Cited by 4
Errazquin, R., Sieiro, E., Moreno‐Sanchez, P. M., Ramı́rez, M. J., Lorz, C., Peral, J., Ortiz, J., Casado, J. A., Roman‐Rodriguez, F. J., Hanenberg, H., et al. (2021) · Genes · doi:10.3390/genes12040548 · Cited by 4
“Dub”bing a tumor suppressor pathway
Niedźwiedź, W., & Patel, K. J. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.018 · Cited by 4
Expression and purification of human FANCI and FANCD2 using Escherichia coli cells
Takahashi, D., Sato, K., Shimomuki, M., Takata, M., & Kurumizaka, H. (2014) · Protein Expression and Purification · doi:10.1016/j.pep.2014.08.012 · Cited by 4
The Ubiquitin/SUMO Pathway and Radial Ray Deficiency Syndromes
Al-Qattan, M. M. (2012) · Annals of Plastic Surgery · doi:10.1097/sap.0b013e318236452b · Cited by 4
Understanding complexity of Fanconi anaemia
Mohanty, D. (2016) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.180196 · Cited by 4
Hereditary Breast and Ovarian Cancer Genes
Scully, R., & Puget, N. (2003) · Humana Press eBooks · doi:10.1385/1-59259-328-3:041 · Cited by 4
Zhang, X., Hou, W., Epperly, M. W., Rigatti, L. H., Wang, H., Franicola, D., Sivanathan, A., & Greenberger, J. S. (2016) · Oncotarget · doi:10.18632/oncotarget.12036 · Cited by 4
Phelps, R. A., Gingras, H., & Hockenbery, D. M. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.034 · Cited by 4
The broken genome: Genetic and pharmacologic approaches to breaking DNA
Woo, L. L., Onel, K., & Ellis, N. A. (2007) · Annals of Medicine · doi:10.1080/08035250601167136 · Cited by 4
Human cytomegalovirus regulates host DNA repair machinery for viral genome integrity
Longmire, P., Zeltzer, S., Zarrella, K., Daigle, O., Svoboda, M., Reitsma, J. M., Terhune, S. S., Bobak, C. A., Bosco, G., & Goodrum, F. D. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1445 · Cited by 3
The Ubiquitin Script: writing protein fates in chains
Gupta, D., & Maddika, S. (2025) · Essays in Biochemistry · doi:10.1042/ebc20253031 · Cited by 3
BRCA1 and BRCA2: Role in the DNA Damage Response, Cancer Formation and Treatment
Savage, K. I., & Harkin, D. P. (2009) · Springer eBooks · doi:10.1007/978-90-481-2561-6_18 · Cited by 3
The emergence of a unified mechanism in the Fanconi anemia pathway
Xu, X., Guo, R., & Xu, D. (2021) · Genome Instability & Disease · doi:10.1007/s42764-021-00053-y · Cited by 3
BRCA1 linked with Fanconi anemia
Holding, C. (2001) · Genome biology · doi:10.1186/gb-2001-2-5-reports0014 · Cited by 3
Milestones in Fanconi Anemia Research
Digweed, M., Hoehn, H., & Sperling, K. (2007) · KARGER eBooks · doi:10.1159/000102546 · Cited by 3
Mirzayans, R., & Murray, D. L. (2008) · The Open Cancer Journal · doi:10.2174/1874079000802010042 · Cited by 3
Les modèles animaux de l’anémie de Fanconi
DUBOIS, E. L., Béliveau, M., & Masson, J. (2016) · médecine/sciences · doi:10.1051/medsci/20163206023 · Cited by 3
Chun, M. J., Kim, S., Hwang, S. K., Kim, B. S., Kim, H. G., Choi, H. I., Kim, J. H., Goh, S., & Lee, C. H. (2016) · Oncotarget · doi:10.18632/oncotarget.10686 · Cited by 3
Ubiquitin and FANC Stress Responses
Williams, S. A., & Kupfer, G. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00272-2 · Cited by 3
Tremblay, C. S., Huang, F. F., Lévesque, G., & Carreau, M. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3243-7 · Cited by 3
Heritable predispositions to childhood hematologic malignancies
Le, D., Shannon, K., & Lange, B. J. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.014 · Cited by 3
Hoatlin, M. E., & Reuter, T. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02042-1 · Cited by 3
López, A., Baida, A., Marcos, R., Xamena, N., & Velázquez, A. (2002) · DNA repair · doi:10.1016/s1568-7864(02)00146-5 · Cited by 3
Clinical, cytogenetic and molecular findings in nine Moroccan patients with Fanconi anemia
Doubaj, Y., Zrhidri, A., Elalaoui, S. C., Lyahyai, J., Kadiri, Y. E., Elkassimi, N., Sbiti, A., Kababri, M. E., Hessissen, L., & Sefiani, A. (2021) · Pan African Medical Journal · doi:10.11604/pamj.2021.39.72.27220 · Cited by 2
Dynamics of Fanconi anemia protein D2 in association with nuclear lipid droplet formation
Hotani, T., Goto, M., Otsuki, Y., Matsuda, S., Wada, N., Shinohara, M., Matsuda, T., Yokoi, M., Sugasawa, K., Ohsaki, Y., et al. (2025) · Journal of Cell Science · doi:10.1242/jcs.264430 · Cited by 2
Arachchi, R. Y. B., Okafor, D. C., Snyder, A. J., & Trakselis, M. A. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103909 · Cited by 2
Moes-Sosnowska, J., Budziłowska, A., & Kupryjańczyk, J. (2015) · Nowotwory Journal of Oncology · doi:10.5603/njo.2015.0002 · Cited by 2
Differential regulation of retinoic acid metabolism in Fanconi anemia
Blaize, J. L., Noori, B. M., Hunter, K. P., Henrikson, K. A., Atoyan, J. A., Ardito, A. A., Chapdelaine, A. G., Sun, G., Donovan, F. X., Chandrasekharappa, S. C., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-50045-9 · Cited by 2
Abdel‐Salam, G. M. H., & Abdel‐Hamid, M. S. (2023) · Clinical Genetics · doi:10.1111/cge.14357 · Cited by 2
Metadata
- Authors
- Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D.
- Affiliations
- Harvard University (US)
- Dana-Farber Cancer Institute (US)
- Hospital for Sick Children (CA)
- Oregon Health & Science University (US)
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 7
- Issue
- 2
- Pages
- 249-262
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W1991841649
- Cited by
- 1,198
- References
- 71
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 14 · 2023: 20 · 2022: 15 · 2021: 24 · 2020: 25 · 2019: 41 · 2018: 28 · 2017: 20 · 2016: 54 · 2015: 49 · 2014: 51 · 2013: 44 · 2012: 66
- FWCI
- 31.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL54785-04, R01HL52725-04, R01HL052725)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK043889, R01DK43889-09)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- Fanconi anemia, BRCA1, FANCD2 monoubiquitination, FANCA, FANCC, FANCF, FANCG, DNA repair, radiosensitivity, mitomycin C sensitivity, synaptonemal complex, meiotic chromosomes, nuclear foci, cancer susceptibility
- MeSH terms
- Animals, Cell Line, Cell Survival, DNA Damage, DNA-Binding Proteins, Fanconi Anemia, Fluorescent Antibody Technique, Genetic Complementation Test, Humans, Male, Meiosis, Nuclear Proteins, Protein Binding, Proteins, Radiation, Ionizing, Spermatocytes, Synaptonemal Complex, Ubiquitins, Ultraviolet Rays, Mitomycin, Cell Cycle Proteins, BRCA1 Protein, Active Transport, Cell Nucleus, Macromolecular Substances, Mice, Fanconi Anemia Complementation Group Proteins, Fanconi Anemia Complementation Group C Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review